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Introduction

Mineral
deposits
from human aortas
and
bioprosthetic
devices
implanted
in experimental
animals
show close
similarities
in chemical
compost ti on,
solubility
and
structural
characteristics.
Chemical
analyses
show
compositions
correspondinq
to a Na, Mg, co 3
substituted
apatitic
calcium
phosphate.
Synergistic
XRO, FT- IR and Raman Microp robe
spectroscopic
data provided
coherent
indication
of Type-B col- incorporation.
Microscopic
and
electron
microprobe
microanalyses,
however,
indicate
substantial
morphological
and spatial
heterogeneity
in the deposits.
Solubility
and kinetic
dissolution
data of
the mineral fraction
of deposits
can be compared
with
the
corresponding
data
of octaca 1ci um
phosphate (OCP). This may indicate
that OCP is
a possible
precursor
phase
which
initiates
formation
of the mineral
deposit.
Our data
i ndi ca te that the deposits
can be represented
by
a
serf es
of
ca rbona te-substi tuted
products,
arisinq
from OCP that has hydrolyzed to varying
degrees.
Dissolution
of
deposits
can
be
described
kinetically
as a surface
controlled
rate process.
The similarities
in the two types
of deposits
suqgest that they form by a common
mecha ni sm (e.g.,
OCP could be the precursor
for
both deposits).

Pathological
calcification
is
a widely
recognized
phenomenon that adversely
affects
the
quality
and span of human life.
It may result
as
a consequence
of a whole
spectrum
of
pathological
conditions
and may occur in many
organs and tissues
in the body.
One of the most
common sites
is
the
cardiovascular
system,
specifically
the aorta.
Modern bioprosthetic
devices and implants have very important uses in
cardiovascular
systems;
however, the functions
of the devices may be impaired by formation of
calcified
deposits.
The severity
of the problem
has
prompted
considerable
research
on
understanding
the
cause
and nature
of the
calcifications.
There is a considerable
body of
information
concerning
atherosclerotic
and
bioprosthetic
calcifications
deriving
from
analytical
[2],
x-ray and electron
diffraction
[2,23,24],
and quantitative
electron
microprobe
analysis
[8,23,25,31]
data.
The formation
of
biomineral
is an extremely complex process,
the
study of which has led to the development
of
several
models for their
formation.
Montel et
al.
[29]
discuss
formation
of the
mineral
component of calcified
tissue
by analogy with
synthetic
systems.
Eanes et al. [11] studied
calcium phosphate precipitation
in multilamellar
liposome
suspensions
as a possible
model for
matrix
vesicle
mineralization.
Boskey
and
Posner [3] provided experimental
evidence
that
phospholipids
control
calcium
phosphate
formation in synthetic
systems, and the presence
of phospholipids
in atherosclerotic
deposits
[10] supports
this model for biomineralization.
There
is
considerable
difference
of opinion
regarding
the
composition
of
cardiovascular
mineral deposits.
Cichocki et al. [7] used the
proton induced x-ray emission
(PIXE) method to
provide
detailed
elemental
analyses
of human
atherosclerotic
artery
wall without
addressing
the question
of the identity
of the deposits.
Krefting
et
al.
[25]
produced
a detailed
electron
microprobe atlas
of mineralized
aortas
and suggested
that the subiritimal
band is the
primary site for mineral deposition.
This
contribution
provides
comparative
information
on composition
and structure
of
aortic
and bioprosthetic
calcifications
in order
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mild luminescence
upon initial
exposure
to the
focused laser spot which quickly diminished
upon
continued
irradiation
providing
acceptable
spectral
background
levels.
Al 1 spectra
were
recorded
with 5 cm-1 spectral
resolution.
We
examined
the
spectra
of
various
calcium
phosphates,
including
hydroxyapatite
(HAP),
ca (P0 ) (0H) ,
octacalcium
phosphate
(OCP),
2
10
4 6
ca 8 H (P0 4 J 6 , and amorphous
calcium
phosphate
2
(ACPJ.
In addition,
a series
of synthetic
carbonate
apatites,
of the Type-A and Type-B
variety,
allowed
us to examine
the
spectral
patterns
for the contri buti ans by colin the
two
lattice
sites.
The
Type-B
carbonate
apatites
consist
of a series
of preparations
with colcontents
varying from
1.5 to
16
wt %, 'and
these
were
used
as calibration
standards
in an empirical
scheme to determine
carbonate
contents.
Optical
properties
of
deposits
were examined by using a Leitz Ortholux
polarizing
microscope.
Cross
sections
of
fractured
pieces
of atherosclerotic
deposits
were examined by scanning
electron
microscopy
(SEM) using a Cambridge 250 Mark II scanning
electron
microscope
equipped
with a Princeton
Gamma-Tech rnx system.
Samples were placed on
an aluminum stub, gold plated and scanned (lo-6
torr,
20
keV,
tilting
angle
QO).
The
compositions
of selected
areas of deposits
were
estimated
after
appropriate
background
corrections.
Solubility
and
dissolution-kinetic
data
were
obtained
by
suspending
finely
ground
deprotei na ted deposits
into diluted
phosphoric
acid
solutions
at the desired
solid/solution
ratios.
Systems were purged with C02/N2 gas
mixtures
in order to suppress
the loss of CO2
from
the
dissolving
medium and
to
assure
reproducible
control
of pH.
Different
C02/N2
mixtures
(0.15-33%) were used to investigate
the
dependency of rate of equilibration
on solution
carbonate
concentration.
The
analytical
concentrations
of
supernatants
of
the
equilibrating
systems were determined
by methods
outlined
above.
The concentration
data
were
used for calculation
of ionic activity
products
( IAP) and
pIAP (defined
in Table
1) for
di calcium
phosphate
di hydrate
(DCPD),
CaHP04 -2H20,
OCP,
/3-tricalcium
phosphate
(/3-TCP), {3-Ca3 (P0 4 ) 2 , and HAP.
Calculations
were performed
by using a program which ta~es
into
account
calcium
phosphate
complex
,on
equilibria
in the
aqueous
phases
[28]
with
emphasis
on carbonate
speciation
and complex
formation.
The calculated
ionic activity
data
were used to provide
addi ti ona 1 i nforma ti on on
the
identity
of
mineral
components
in
cardiovascular
deposits.
Three approaches
were
attempted:
(a) comparison
of IAP's with the
corresponding
solubility
product
values
of
calcium phosphates
listed
above, (b) application
of chemical
potential
plots
p(H+)3(Po 4 3-) vs.
p(ca2+)(0H-) 2 [28] to characterize
the solutions
obtained
in
successive
equilibrations;
these
provided
new information
on the chemical nature
of
deposits,
and
(c)
kinetic
treatment
of
dissolution
data to test the findings
of {a) and

to better
understand
the mechanism of deposit
formation,
with the ultimate
goal of developing
protocols
for
its
prevention.
Thermodynamic
solubility
and dissolution
kinetic
data complement the classical
physicochemical
characterization
methods to pro vi de more comp1ete i nformati on on pathologic
minerals
and their possible
precursors.

Materials* and Methods
Two types of deposits
have been examined:
(a) atherosclerotic
calcified
plaque
isolated
from the intima
layer
from human subjects
and
(b) bioprosthetic
calcifications
occurring
on
surfaces
of left
ventricular
assist
devices
(LVAD) implanted
into experimental
animals.
The
details
of isolation,
treatment,
quantitative
deproteination
and storage
of materials
used in
these
studies
will
he described
subsequently
(Tomazic et al.,
manuscript
to he submitte<i to
Atherosclerosis).
Chemical
analyses
were
performed
by dissolving
deproteinated
deposits
and determining
the Ca, Na, Mg, K, Sr and Ph
contents
by atomic
absorption
spectroscopy.
Phosphate
contents
were
determined
spectrophotometrically
using
the
molybdate-vanadate
method [18]:
HP04 2- content
was estimated
after
pyrolysis
of deposits
(24 h, 4050C, 0.1 torr),
from
the
difference
in
spectrophotometric
readinqs
from
hydrolyzed
and
unhydrolyzed
aliquots
[17].
Carbonate
content
in
the
deposits
was <letermined by microtitration
using
a modifie<l Conway microdiffusion
method rq7_
X-ray diffraction
(XRD) patterns
were recorded
using a Philips
automated Powder Diffractometer,
ADP 3600.
The powder patterns
were compared
with the Joint
r:ommittee of Powder Diffraction
Standards
values
for
representative
calcium
phosphate
compoun<ls.
Infrared
spectra
of
deproteinated
deposits
(2 mg/400 mg KBr pellet)
were recor<led using a Nicolet
7000 series
FT-IR
spectrophotometer.
Direct molecular
information
on structure
and composition
has been gained
from investigations
using conventional
FT-IR and
Raman microprohe spectroscopy.
Raman microprobe
analysis
was performed
with the microprobe
develope<l at the National
Bureau
of
Standards
[ 14 J.
The
instrument
employs an Ar+/Kr+ gas laser
to excite
the
spectra
with
514.5
nm excitation.
The
measurements were performed on powdered samples
of these calcified
deposits.
Spectra of single
particles
(size
ranqe 5-50 µm) of the powders
dispersed
on lithium
fluoride
substrates
were
recorded.
Laser
power densities
directed
at
these samples ranged from 5-20 mWin a beam spot
of
10 µm diameter.
The native,
non-deprotei na terl samples of these deposits
showed some
*Certain
commerc, a 1 materi a 1s and equipment are
identified
in
this
paper
to
specify
the
experimental
proce<lure.
In no instance
<loes
such
identification
imply
recommendation
or
endorsement
by the National
Bureau of Standards
or
the
ADA Health
Foundation
or
that
the
material
or equipment identified
is necessarily
the best available
for the purpose.

{h).
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TABLE1
Ionic

Activity
Products Obtained by Reequilibrations
Deproteinated
Aortic Deposit
10-Hy.
pIAP

Co11pound

st.dev.

pKsp

I

OCP

48.49

0.45

49.5

2.0

OCP
/3-TCP

48.49
29.23

0.45
0.41

48.6
28.91

0.2
-0. 1

HAP

5 3. 18

0. 77

58.55

9. 2

DCPD

6. 9 2

pIAP(DCPD)
-log
pIAP(OCP)
-log
p I AP (/3- TCP)
- 1o g
pIAP(HAP)
-log
% = ~sp-pIAPxlOO
pKsp
ss = supersaturated;%>
US = undersaturated;

0.05

Condition

ss
ss
us
ss
us

-4.8

6.60

of
for

Ref.
pKsp
( 35)
(22)
( 20)
( 28)
( 19)

[(Ca2+)(HPo
4 -JJ
[(ca2+)4(po
4 3-J3(H+)J
[ ( Ca 2 + ) 3 ( PO4 3 - ) 2 ]
[(ca2+)5(P043-J3(oH-J]

%

<

O
0

TABLE2
Chemical Compositions
(8) Deposits,
thetfc
Ca/P
n

of Deproteinated
(A) and BioprosAtherosclerotfc
Expressed
in Molar Ratios with Standard Deviations.
Mg/P
Na/P
C03/P
Ch. Bal.
I C03

(A)

10

1 . 73
( 0. 06)

0.043
(0.007)

0.063
(0.006)

0.244
(0.024)

6.99
( 0. 59)

0.142
(0.076)

( B)

3

1. 75
( 0. 08)

0.048
( 0. 00 3)

0.047
( 0. 0 20)

0.238
( 0. 01 7)

6. 91
( 0. 37)

0. 1 59
( 0. 134)

Results

which
is
almost
identical
to
bioprosthetic
deposit:
Cag_73Mgo_24Nao.24Ho.14(P04)5(C03)1.2
(OH,Cl,Flo.9·

Chemical Composition
The average results
from detailed
chemical
analyses
of 10 rleproteinatect
atherosclerotic
and
three deproteinated
bioprosthetic
deposits,
with
correspondinq
stanrlard
ctevi ati ons, are outl inect
in Table 2.
The compositions
are very similar
regardless
of the fact
that
the human aortic
deposits
(patient
age group 45-80 y) generally
develop
over a much longer
time period
than
hioprosthetic
deposits
(up to
five
months).
Analyses of four native aortic
deposits
and four
native
bioprosthetic
materials
showed
HPo4=
contents
of 3.0% (s = 0.7%) anct 2.8% (s = 0.8%)
of total
phosphate,
respectively.
Kuhl and
Nebergall
[26) suggested
that the composition
of
nonstoichiometric
carbonate
apatite
can
he
expressed
as follows:
Ca10-x-y(P04l5-x(HP04,C03lx(OHl2-x2Y·
When the ctata from Table 2 are translated
into
such an expression,
the composition
of aortic
deposit
becomes:
Ca8.66Mgo.22Nao.32Ho.15(P04)5(C03l1.22
(OH, C1 , F) o . 8,

that

of

SEMand EDXData
SEM provided
information
suggesting
that
the
inorqanic
matrix
may
be
spatially
heterogeneous.
This is well illustrated
in Fig.
l a-c.
The chemical
compositions
of cteposits
with representative
morphologies
were determined
by EDX and are representect
as usual by the Ca/P
ratios,
as follows:
Fig. la:
smooth spherical
particles,
Ca/P
1.56;
Fig.
lb:
irregular
particles
of rather
constant
size,
Ca/P = 1.68;
Fig. le:
layer type scale (most abundant),
Ca/P
l. 79.
The morphological
findings
are
in
accord with observations
of Schmid et al. [33)
who as sumect that
"the surface
of the ctepos its
have a composition
essentially
the same as the
entire
deposit,"
which
may
be
an
oversimplification.

X-ray Diffraction
X-ray
cardiovascular
structural
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atherosclerotic
and bioprosthetic
deposits
are
practically
identical.
Materials
are
microcrystalline,
in
accordance
with
other
reports
[24,33]
XRD yiel<1e<1 apatitic
patterns,
compatible with those of HAP and OCP, but devoid
of lines
characteristic
of DCPD, ,B-TCP, or
whitlockite.
Calculations
of lattice
parameters
show an average 0.47% decrease in the a-axis and
a 0.03% increase
in the c-axis.
This is in
accord with the proposed carbonate-for-phosphate
substitution
(Type-8) in the hexagonal apatitic
structure
[27] and our finding
of average
7%
carbonate content in the rleposits.

IR-Spectroscopic Analysis
FT-IR
spectra
of
atherosclerotic
and
bi opros thet i c dep rotei na terl depos i ts a re shown
in Fig. 2.
The spectra
are very similar
and
show absorption
bands at 872, 1417, 1452 and
1470 cm-1 which can be assignerl
to carbonate
substituting
for
phosphate
in
the
apatitic
(Type-8) structures
[12,13,27].
The absence of
the 1545 cm-1 band assignable
to
carbonate
substituted
for
hydroxyl
[SJ
is
significant
because
it
indicates
minimal or absence
of
Type-A substitution.

Ra1111.n
Microprobe Analysis
The
application
of
Raman microprobe
spectroscopy
to these i nves ti ga ti ons represents
an extension
of earlier
micro-Raman work on
mineralizing
biological
tissues,
which had shown
that
such
measurements
can
be
performed
nonintrusively
and
that
the
spectra
lend
themselves
to useful
interpretation
[5,15,21].
The primary
goal was to obtain
corroborative
molecular-specific
information
on the apatitic
phase, especially
with respect
to the type of
carbonate
substitution
(substitution
of C032for either
Po4 3- or OH-, or both)
in these
biological
calcium
phosphates.
Secondly,
an

..
0"'

..

,, "',, ,,

-

w

<O
CD

(.)

z

2:

c(

ID

a:
0

en
ID
c(

1600

1400

1200

1000

800

WA VENUMBERS

Fig. 2. COllll)aratfveFT-IR adsorption spectra of
deproteinated
atherosclerotic
(1)
and
bioprosthetic (2) deposits.
2 111!Jsample/400 111g
KBr pellet.

Fig. la-c.
Scanning electron micrographs of
fractured.
deprotefnated.
atherosclerotic
deposits.
(a) Ca/P = 1.56; (b) Ca/P = 1.68; (c)
Ca/P = 1. 79.
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carbonate
apatite,
ca 10 (P0 4 ) 6co 3 , containing
5.8
wt% co/-,
appears
at frequency
shift
of 1110
cm-1: thus, it can readily
be distinguisherl
from
its Type-B counterpart.
The weak bands centered
at ~2920 cm-1 and at ~3575 cm-1 are attributed
to 0-H stretching
modes of the hydroxyl ions in
the carbonate
apatite.
In the spectrum of the
aortic
plaque,
the weak hanrl with maximum at
~2940 cm-1
is
assigned
to
C-H stretching
vibrations,
this
band being a weak remnant of
the
incompletely
removed
organic
matrix.
Carbonate contents
of these calcified
rleposits
are
determined
by
an
empirical
procerlure
utilizing
the scattering
data from a series
of
synthetic
carbonate
apatites.
This
involves
determining
the intensity
ratios
of the ~1075
cm-1 carbonate
band and the ~961 cm-1 phosphate
band,
with
appropriate
corrections
for
the
spectral
"backgrounrl"
at
each
of
these
analytical
frequencies.
This method of quantitation
of carbonate
contents
of the mineral
phase of human aortic
plaque yields
an average concentration
of 6.2 wt
% co 3 2- based on the measurement
of several
arbitrary,
single
particles.
Similar
results,
with an average value of 6.4 wt % col-,
were
obtained
for deprotei na ted bi opros thet, c p 1aque
based
on
an
equal
number
of
particle
measurements.

attempt
is
made here
to quantify
carbonate
contents
from the scattering
rlata obtained
in
the
microscopic
rlomain.
Presenterl
are
the
micro-Raman spectra
(Fig.
3) of deproteinated
aortic
plaque and that of a synthetic
Type-B
carbonate
apatite
with
4.3% carbonate content.

Human Aortic Plaque
(deproteinated)

z
-i

m
z
en
=i

Carbonate Apatite, Type B
(synthetic,,-,4.3 wt% COf)

-<

Optical Microscopy Analysis

3500

3100

2700

1200

800

400

Optical
microscopic
examinations
of
pul veri zerl deposits
provided addi ti ona 1 data in
accord
with
the view that
the material
is
relaterl
to OCP. Generally,
the materials
were
morphologically
heterogeneous,
displaying
weak
birefrinqency.
Aortic deposits
were represented
mostly by three morphologies
resembling
square
shaped agg·1omera tes,
"coa 1-1 i ke" conglomerates
with "diamonds" inside,
and irregular
particles.
The refraction
index, N, for the majority of the
particles
was
about
1.58,
ranging
from
1.55-1.59.
8ioprosthetic
deposits
comprised
more homogeneous populations
of particles
with
sliqht
"length
slow" birefringence
and with
refraction
indices
above 1.55, but below 1.59.
The observed refraction
indices
can be compared
with the OCP values N0 = 1.576, N13 = 1.583 and
N-y = 1.585 and are in sharp contrast
to the HAP
values,
Nt
1 .64 and Nw = 1.646 [41.
The
refractive
indices
of
carbonate-substituted
apatites
cover a range from 1.61-1.64 [11, i.e.,
less
than the corresponding
HAP indices;
by
analogy,
that
suggests
that
the
deposits
represent
a continuum
of carbonate-containing
hydrolytic
products of OCP.

0

RAMAN SHIFT (dcm· 1 )

Fig.
3.
Microparticle
Ranan spectra
hUllllln aortic
deposit deprotefnated
by
treatment
and (ii)
synthetic
Type-8
apatite
(4.3% w/w carbonate).
Spectra
particles
(~ 20 µm size)
supported

substrate.
Excitation
spectral range.

at

514.5

of (i)
hydrazine
carbonate
of single
on a LiF

nm; partial

The spectra
display
a striking
similarity
anrl
are a true reflection
of the similarities
in the
composition
and molecular
structure
of
the
biological
versus
the
synthetic
carbonate
apatite.
The principal
features
in both of
these
spectra
arise
from the
Raman active
vibrations
of the P04 3- and colions.
The
internal
vibrational
morles of the
phosphate
group give rise to shifts
to about 961 cm- ( v 1
P-0 symmetric
stretch),
432 anrl 455 cm-1 ( v 2
morles), 582, 593 and 610 cm-1 (v 4 modes), and
1030, 1048 anrl 1079 cm-1 ( v 3 morles).
The
group in the synthetic
carbonate
apatite
has as
its strongest
feature
a band at ~1075 cm-1 (v 1
C-0 symmetric stretch)
characteristic
of Type-B
substitution
in the lattice.
The equivalent
carbonate
banrl ( v,) in fully
substituted
Type-A

Solubility

of Deposits

The results
of eight
successive
equilibrations
of
a deproteinated
atherosclerotic
deposit
(sample 10-Hy) with 1 mM H3 Po4 (20 g/L,
5% CO2 , Exp. E-8) are shown in Fig. 4.
The
first
equilibration
resulted
in
substantial
1ea chi ng of Na and Mg from the deposits.
After
the
fourth
equilibration
the
solution
concentrations
became relatively
constant,
and
Na and Mg leachinq
was greatly
reduced.
This
behavior suqges ts that a ma.ior portion of Na and
Mg is
surface
bound.
The pIAP values
for
various
calcium
phosphates
were
calculated

r:oi-
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p IAP (OCP)
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E
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N
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+<O

u

z

~

0

j::

pH

<
a: 1.0
I-

7

C.

18

z

w
(.)

z
0

(.)

17~--~

____
27

6

0.5

.,_____
28
p(H+)3(pQ

4

30

3 -)

Fig. 5. CheMical potential plot of p(H+)3(P043-,
VS:-,,(Ca2+)(0H)2
for repeated equi libratfons
of
deproteinated
atherosclerotic
deposit
10-Hy.
oExp. E-8. 20 g/L 1 wl4 H3 Po4 , 51 CO2 • total bulk
dissolution
9.51;
,:,.Exp. E-6. 17.5 g/L 20 nfll
HCL. CO2 = O. total bulk dissolution
351.
HAP (ref. [28)).
---- OCP (ref. [22)), and
/3-TCP (ref.
[20))
isothenns.
2s 0 c. The field
below a curve represents
supersaturation
(SS),
and the field
above that
curve represents
undersaturation
(US) with
respect
to
the
indicated solid phase.
The first
equilibration
and the last
equilibration
in sequence are
numbered.

0
2345678

EQUILIBRATION

-L___J

.....J.._ ___

29

no.

Fig.
4.
Repeated equilibrations
of atherosclerotfc
deproteiMted
deposit
sample 10-Hy
with 1 ""1 H3 Po4 (20 g/L. 51 CO2 • Exp. E-8).
o Ca. □ P.
,:,.Na. • Mg concentration
and 'J pH
data;
,. pIAP(OCP) data to be collll)ared with
pKsp(OCP) values 1:
49.5 (ref.
[22]) and 2:
48.5 (ref. [35)).

OCP: therefore,
we attempted
to characterize
the
dissolution
kinetics
using OCP as the dissolution model.
As shown by numerous experiments,
the rate of equilibration
is insensitive
to the
stirring
rate,
increases
with
solid/solution
ratio,
and
decreases
as
the
relative
CO2
pressure
increases.
The dissolution
process can
be characterized
by the rate equation:

following
each equilibration,
and the trend of
p!AP(OCP) is shown in Fig. 4.
The calculated
values
fall
mostly
between
the
two recently
reported
values
of pKsp(OCP) = 49.5 [22] and
48.6 [35].
A summary of the average values of
p!AP, the corresponding
standard
deviations,
and
the
corresponding
supersaturation/undersaturation
values
for equilibrated
suspensions
is
given in Table 1. At apparent
equilibrium,
the
suspensions
are very close
to saturation
with
respect
to OCP and ,6-TCP, hicihly supersaturated
with respect
to HAP and highly
undersaturated
with respect
to DCPD. The same equilibration
data were used in the chemical
potential
plot
shown in Fig. 5. There is an apparent
trend in
the
p(H+)3(po 4 3-)
vs.
p(Ca2+)(oH-)2
data,
indicating
that
reequilibration
produces
a
better
fit to the OCP isotherm and diverges
from
the {3-TCP isotherm with increasing
equilibration
nuMher. The equilibrated
suspensions
are highly
supersaturated
with respect
to HAP, even after
15% of the deposit
has dissolved
(Exp. E-6).
This rules
out HAP as a major equilibrating
phase in atherosclerotic
deposits.
Similar
data
were obtained
with
other
atherosclerotic
and
hioprosthetic
deposits.
Kinetic
Interpretation
of
Dissolution
of
Deposits
Dissolution
of deproteinated
aortic
deposit
appears
to he a kinetically
controlled
process.
As shown above, the thermodynamic solubility
of
cardiovascular
deposits
approximates
that
of

R = (Ht/Wi )2/3
where Kd = rate
(Wt/Wi)2/3

d( IAP(OCP) )1/8/dt

=

Kdst.n

(1)

constant

= solid-to-solution

correction

factor

('.AP(OCP)l/8 - Ksp(OCP)l/8)
= undersaturat1 on parameter
IAP(OCP)
(ca2+)4(po 4 3-)3(H+) = ionic activity
product for OCP

t.=

thermodynamic
OCP
n

reaction

s = surface

order
area

solubility

product

for

and
parameter.

A typical
dissolution-rate
profile
(Fig.
6a)
shows that under a given set of conditions
(0.5
g/L 0.2 mM H3 P04 , 1% CO2 , 37°C),
70% of OCP
saturation
is accomplished
within
two hours.
Kinetic
treatment
of
the
the
dissolution
process,
given by log-log plots of equation
(1 ),
yields
the value of n from the slope (Fig. 6b).
In general,
the dissolution
of cardiovascular
mineral
using
the
OCP dissolution
model is
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Fig.
6a-b.
Dissolution
of atherosclerotic
deprotefnated deposit sample 7-3-Hy (Exp. D-48,
0.5 g/l 0.2 nf1I H3P04, 1S CO2, 370C).
(a)
IAP(OCP)l/8 vs. time (kinetic profile);
(b) -log
R vs. -log
c. treatment of (a) data, slope n =
2.3.

E

,..,

0.8

as

(.)
.....

0.4

characterized
by values of n = 2 to 3.
For
example in the case of Exp. D48, n = 2.3.
This
supports the concept that 11nder these conditions
dissolution
is a surface controlled
rate process
and in this manner parallels
the mechanism of
dissolution
of kidney stones [34].

Effect of Carbonate on Dissolution

500

0

.....

of Deposits

C

62

A.

nissolution
processes
were
studied
in
systems
saturated
with
co2 /N2 gas mixtures
ranging
from 0.15 to 33% CO2. CO2 in the
dissolution
medium lowers
the
pH of
the
suspensions,
resulting
in increased
solubility
of the deposits.
On the other hand, increased
CO2 pressure
markedly slows down the rate of
approach
to equilibrium.
These events
a re
illustrated
in Fig.
?a-c.
The changes
in
pIAP(OCP) vs. time reflect
the effects
of CO2 on
the rate of approach to equilibrium.
The kinetic
treatment
of dissolution
data, outlined
in the
preceding
section,
proves the validity
of eq. l
for characterizing
the rlissolution
of deposits
as surface
control led rate processes
(n = 2-3)
over the whole range of COz partial
pressures.

0

0

a.

58

c(

C.

54

TIME

(min)

Fig.
7a-c.
Dissolution
of
deproteinated
atherosclerotic
deposits.
Effect of CO2 partial
pressure on rate of equilibration.
□ 0.151,
o 1.01, c. 5.01 and • 331 CO
2 in co 2 /N2 gas
mixture.
(a) pH, (b) Ca and (c) pIAP(OCP)
kinetic profiles.
0.5 g/L 0.2 nf1IH3P04, 37°c.

Discussion
Our results
provide conclusive
information
on the striking
similarity
of atherosclerotic
and
bioprosthetic
calcified
deposits.
The
compositions
are
in general
agreement
with
literature
reports
on
the
nature
of
atherosclerotic
calcifications
[2,23-25].
Our
data provide
a more detailed
physicochemical
characterization,
particularly
of solubilities
and dissolution-rate
parameters
of pathologic
deposits.
The empirical
formulae of deposits
given above are oversimplifications,
useful for
easier
comparison of the chemical compositions.
These formulae do not necessarily
provide the
structural
information
necessary
to conclude
that
the two types of deposits
have common

structural
features
and, therefore,
a common
mechanism of formation.
The spectra
of the aortic
plaques
and
bioprosthetic
calcified
deposits
- both in their
native
and deproteinated
states
- are
very
similar
and,
in fact,
closely
resemble
the
spectra
of other
mineralized
tis sues
(e.g.,
chick bone) studied in previous work [5].
These
corroborative
studies with the Raman microp robe
have provided
a consistent
picture
of the
composition
of these
ca 1cifi ed deposits
as
consisting
of a microcrystalline
mineral phase
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present
in a complex, bio-organic
host material,
with
the
mineral
best
described
as
a
carbonate-hearing
(Type-8),
"impure" biological
apatite
different
from a stoichiometric
HAP.
The SEM and microprobe
rlata inrlicate
that,
at
the microscopic
level,
these calcific
rleposits
clearly
show a fair degree of heterogeneity
in
morphology and composition:
this
is also borne
out
by the
Ca/P ratios
obtained
by x-ray
microanalysis.
Contrary
to some predictions
that such mineralized
deposits
may also contain
carbonate
moieties
substituted
for hydroxyl
in
the structure
of the biologic
apatite,
we rlid
not detect
the presence
of Type-A carbonate
apatite
in our spectra [16).
In ongoing work we
are closely
scrutinizing
the vibrational
spectra
(micro-Raman and FT/IR) to possibly
reveal
the
presence of OCP and its hydrolyzates
whic~ have
been proposed as precursors,
or participants,
in
the
formation
of
cardiovascular
calcified
deposits.
Solubility
rlata complemented with optical
microscopic
data
provide
the essentially
new
information
that
cardiovascular
calcification
cannot be representerl
as HAP. More plausibly,
this heterogeneous
phase can be representerl
as a
series
of·
hydrolyzed,
carbonate-substituted
products
arising
from OCP. The similarity
in
the two types of deposits
suggests that they a re
formerl by similar
mechanisms even though the
atherosclerotic
rleposits
initiate
subintimally
[2'i],
while
bioprosthetic
rleposits
form
in
direct
contact
with bloorl.
The mathematical
model for calcium
phosphate
crystal
formation
has been recently
provided by Nelson [32].
The
model includes
nucleation
sites
in tissue
in
which
growth
is
controlled
by
inhibitors.
However, the irlentity
of precursors/phases
was
not rliscussed.
It has been documented that OCP
(but not HAP) forms in ultrafiltered
serum when
it has been marle supersaturated
with respect
to
both OCP and HAP (Eidelman
et al.,
private
communication).
This
introduces
OCP as
a
possible
precursor
in cardiovascular
deposit
formation.
OCP readily
forms
in
aqueous
solutions
as
a
kinetically
favored,
but
unstable,
phase.
This finding
is in accordance
with the general
scheme of the mechanism of
biological
mineralization,
which emphasizes
the
importance
of kinetic
parameters
[30].
The
formation
and conversion
of OCP is affected
by
the composition
of the solutions;
Mg2+ and C □ 1 2 markedly stabilize
OCP, slowing its hydrol{.s,s:
and carbonate
uptake takes place when C03 - is
present,
resulting
in the formation
of poorly
crystallized
Type-B
carbonate
apatite
[Ii].
These
sequential
events
are
presented
schema ti ca 11y,

1

slow
I
I

;.

HAP

Aclcnowledgaent
The authors
American Dental
and EDX data.

acknowledge
Association,

J. Lenke of
Chicago,
for

the
SEM

References
1.
Biggar GM. (1968).
The correlation
of
refractive
index with substitution.
The Indian
Mineralogist
B, 35-44.
2.
Bigi-A, Foresti
E, Incerti
A, Ripamonti
A, Roveri N. (1980).
Structural
and chemical
characterization
of the inorganic
deposits
in
calcified
human aortic
wall.
Inorg. Chem. Acta.
55, 81-85.
3.
Bos key AL, Posner AS. (1977).
The role
of synthetic
and bone extracted
Ca-phospholipidphosphate complexes in hydroxyapatite
formation.
Calcif.
Tiss. Res. 23, 251-258.
4. Brown WE, Smith JP, Lehr JR, Frazier AW.
(1962).
Octacalcium
phosphate
and
hydroxyapatite.
Nature 196, 1048-1055.
5.
Casciani
FS, Etz ES, Newbury DE, Doty
SB. (1979).
Raman microprobe
studies
of two
mineralizing
tissues:
Enamel of the rat incisor
and the embryonic chick tibia.
Scanning Electron
Microsc.
1979; II: 383-385.
6. Chickerur NS, Tung MS, Brown WE. (1980).
A mechanism for incorporation
of carbonate
into
apatite.
Calcif.
Tissue Int. 32, 55-62.
7. Cichocki T, Heck D, Jarczyk L, Rokita E,
Strzalkowski
A, Sych M. ( 1985).
Elemental
composition
of the human atherosclerotic
artery
wall.
Histochemistry
83, 87-92.
8.
Coleman DL, Dm D, Kessler T, Andrade
JD.
(1981).
Calcification
of
nontextured
implantable
blood pumps. Trans. Am. Soc. Artif.
Intern.
Organs 27, 97-103.
9.
Conway EJ. (1962}.
Microdiffusion
Analysis
and Volumetric
Error,
C. Lockwood,
London, p. 201.

..

OCP

i ~Di

W.E. Brown

where OCPH represents
an ill-defined
product
obtainerl
when OCP hydrolyzes
in situ
(OCP
hydro lyza te).
The above schema is suggested
as a model
for
the
formation
of
biological
apatites.
Additional
complications
are
created
by the
presence
of a variety
of biologically
active
compounds which additionally
can control
the
rates
of
hydrolysis
and
"maturation"
of
precursors.
The
final
product
would,
consequently,
comprise a series
of OCP-carbonate-hydrolyza
tes,
which are generally
referred
to as "defect
apatites,"
in agreement with our
findings with cardiovascular
deposits.
The presence
of
OCP in
cardiovascular
deposits
has
been documented
by
electron
diffraction
[23).
This is in agreement with our
view that hydrolysis
of OCP contributes
to the
heterogeneity
of these deposits.
The chemical
potential
plots
and kinetic
data additionally
support
this
proposition.
The products
are
significantly
more soluble
than well-crystallized
HAP, and one may expect that it is the
degree of sa tura ti on of blood with respect
to
OCP that controls
formation of these deposits.

Soln. ca2 + Po43.:._
I
I
I
fast

OCPH

Etz,

medium

Carbonate Apatite

102

Nature and Properties of Cardiovascular Deposits
26.
Kuhl
G,
Nebergall
WH. (1963).
Hydrogenphosphate
and carbonapatite.
Z. Anorg.
Allg. Chem. 324, 313-325.
27. LeGeros RZ. (1967).
Crystallographic
studies
on the carbonate
substitution
in apatite.
Thesis, New York University.
28.
McDowell H, Gregory
TM, Brown WE.
(1977). Solubility
of Ca5(P04l30H in the system:
Ca(OH)2-H3P04-H20 at 5, 15, 25, and 37oc. J. Res.
Nat. Bur. Stand.
(U.S.)
81A, Numbers 2 and 3,
273-281.
29. Mantel
G, Bonel G, Heughebaert
JC,
Trombe JC, Rey C. (1981).
New concepts
in the
composition,
crystallization
and growth of the
mineral component of calcified
tissue.
J. Cryst.
Growth 53, 74-99.
30~Nancollas
GH. (1977). The mechanism of
biological
mineralization.
J. Cryst.
Growth 42,
185-193.
31. Nelson AC, Schoen FJ, Levy RJ. (1985).
Scanning
electron
microscopy
methodology
for
study
of pathophysiology
of calcification
in
bioprosthetic
heart
valves.
Scanning
Electron
Microsc. 1985; I: 209-213.
32. Nelson AC. (1986).
Theory for calcium
phosphate
crystal
formation
in
tissue
from
scanning
electron
microscope
data.
Scanning
Electron Microsc. 1986; I: 151-156.
33. Schmid K, Mcsharry
WO, Pameijer
CH,
Binette
JP. (1980). Chemical and physicochemical
studies
of the mineral
deposits
of the human
atherosclerotic
aorta.
Atherosclerosis
37, 199210.
34. Tomazic BB, Nancollas
GH. (1982).
The
dissolution
of calcium oxalate
kidney stones.
J.
Uro l. 128, 205-208.
3S:-Tung MS, Eidelman N, Sieck BA, Shih AY,
Brown WE. (1986).
The solubility
of octacalcium
phosphate
at 4, 12, 18, 23 and 37oc. J. Dent.
Res. 65, 263, abstract
845.

10.
Dmitrovsky
E,
Boskey
AL.
(1985).
Calcium-acidic
phospholipid-phosphate
complexes
in human atherosclerotic
aortas.
Calcif.
Tissue
Int. 37, 121-126.
IT. Eanes ED, Hailer AW, Costa JL. (1984).
Calcium
phosphate
formation
in
aqueous
suspensions
of multilamellar
liposomes.
Calcif.
Tissue Int. 36, 421-430.
12. Elliott
JC. (1973).
The problems of the
composition
and
structure
of
the
mineral
components of the hard tissue.
Clin. Orthoped.
93, 313-345.
13.
Elliott
JC,
Holcomb DH, Young RA.
(1985).
Infrared
determination
of the degree of
substitution
of hydroxyl
by carbonate
ions in
human dental
enamel.
Calcif.
Tissue
Int.
37,
372-375.
14.
Etz ES. (1979).
Raman microprobe
analysis:
Principles
and applications.
Scanning
Electron Microsc. 1979: I: 67-92.
15. Etz ES. (1981).
Empirical
quantitation
in
Raman mi croprobe
analysis.
Microbeam
Analysis,
1981, 73-78.
16. E~ES,
Tomazic BB, Brown WE. (1986).
Micro-Raman characterization
of atherosclerotic
and
bioprosthetic
calcification.
Microbeam
Analysis,
1986, 39-46.
17. Geei'i, Dietz VRJ. (1955).
Pyrophosphate
formation
upon ignition
of precipitated
basic
calcium phosphates.
J. Am. Chem. Soc. 77, 29612966.
18. Greenberg
EA, Connors JJ, Jenkins
D,
Franson MAH. (eds.)
{1981).
Standard Methods for
Examination
of Water and Wastewater,
15th ed.
Prepared and published
jointly
by American Public
Health
Association,
American
Water
Works
Association,
Water
Pollution
Federation,
Washington,
DC, p. 415.
19. Gregory TM, Moreno EC, Brown WE. (1970).
Solubility
of CaHP04-H20 in the system Ca(OH)2H3P04-H20 at 5, 15, 25, and 37.5°C.
J. Res. Nat.
Bur. Stand.
(U.S.) 74A (Phys. and Chem.) Number
4, 461-475.
20. Gregory TM, Moreno EC, Patel JM, Brown
WE. (1974).
Solubility
of
S-Ca3(P04)2 in the
system Ca(OH)2-H3P04-H20 at 5, 15, 25, and 37°C.
J. Res. Nat. Bur. Stand.
(U.S.)
78A (Phys. and
Chem.) Number 6, 667-674.
21. Grynpas MD, Etz ES, Landis WJ. (1982).
Studies
of calcified
tissue
by Raman microprobe
analysis.
Microbeam Analysis 1982, 333-337.
22. Heughebaert
JC, Nancol las GH. (1985).
Solubility
of octacalcium
phosphate
at 25° and
45° C in the system Ca(OH)2-H3P04-KN03-H20. J.
Chem. Eng. Data 30, 279-281.
23. Hohling
HJ, Fearnhead
RW, Lotter
G.
(1968).
The mineral
components
in
aortic
"calcification"
studied
by x-ray
and electron
diffraction
combined with electron
microscopy.
German Med. Math. 13, 135-138.
24. Kim KM,-Trump BF. (1975).
Amorphous
calcium
precipitation
in human aorta.
Calcif.
Tiss. Res. 18, 155-160.
25.
Krefting
ER, Rohrig
T, Brocker
W,
Anyanwu E, Schlake W, Dittrich
H, Hohling HJ.
(1982).
Mineralization
of human aortas
with
coarctation:
quantitative
electron
microprobe
analysis.
Scanning
Electron
Microsc.
1982; IV:
1617-1628.

Discussion with Reviewers
T. H. Jordan:

Is it necessary
to read reference
in order
to learn
how to obtain
the
composition
formulas presenter1 in the text?
The
reader
is told that nonstoichiometric
carbonate
apatite
can be expressed
as
Ca10-x-y(P04)6-x
(HP04,C03lx(OHl2-x-2y•
The statement
is
then
made that the data in Table 2 translates
into
Ca8.66Mgo,22Nao.J2Ho.15(P04)5(C03)1.22
(OH,Cl,Flo.8,
A simple comparison
of these
two formulas,
outlined
in Results section,
suggests:
From (HP04,C03) x = 1.22 + 0.15 = 1.37
From (P04) 6 - x = 5 - 0.15 = 4.85 or x = 1.15
Clearly
x cannot have both these values.
These
two values of x would both be 1.26 if the amount
of H were raised
from 0.15 to 0.26,
but then
charge balance
would no longer
hold.
Perhaps
the (OH) could be adjusted
to take this
into
account.
If reference
[26] does not give an
explanation,
then I would suggest
the authors
give a little
more guidance to the reader.

[26]
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Authors:
The composition
formula of 10 hydrazine deproteinated
atherosclerotic
deposits
was
<lerived from chemical
analysis
of Ca, Mg, Na,
HP04, P04, C03 contents,
which gave average composition
Ca3_ 0 5Mgo.22Nao_32Ho.1s(P04)5(C03)1.22Charge
balance
for
this
composition
was
calculated
by summation of positive
and negative
ionic charges:
(8.66 x 2 + 0.22 x 2 + 0.32 +
0.15) - (5 x 3 + 1.22 x 2) = 0.8.
The charge
balance
+0.8
was assigned
to
(OH, F, Cl)
composition
which was the only calculater!
group
of constituents.
This
mathematical
approximation
can be affected
by analytical
error
( HP04, C03 up to 5%) or by oversi mp1ifi cation of
the state of carbonate,
the portion of which may
be incorporater!
as HC03 group.
[This discussion
can help to accept
the calculated
gap in X
value.]

W.E. Brown

We believe
that
the structural
and solubility
properties
of this OCP hydrolyzate
comprise two
of the most important
unanswered questions
in
biomineral
research.
The range of sol ubi 1 i ty products
of OCPH
expressed
in the terms of OCP is similar
to, but
slightly
lower than that of the most probable
va 1ue for OCP. A decrease
is expected
because
the hydrolysis
of OCP in vivo is spontaneous
and
should therefore
1ead To aproduct
with reduced
solubility.
The solubility
product of carbonate
substituted
calcium
phosphate
would certainly
have a different
numerical
value than Ks_pOCP,
but at present
we do not know how it should be
formulated.
RevfewerII:
Do the
3
distinctly
different
morphologies
illustrated
in the SEM figure (Fig.
1) represent
3
separate
types
of
mineral
deposits
or the same type of deposit but at 3
different
stages of maturation?
Authors:
SEM figures
represent
only
most
abundant morpho 1ogi es; other mi nor morpho 1ogi es
are present
as wel 1.
One can anticipate
that
the
surrounding
media,
i.e.,
organic
matrix
composition,
may greatly
affect
the maturation
of inorganic
matrix.
Therefore,
variability
of
morphologies
and Ca/P composition
is
to be
expected.
This
suggests
that
the maturation
process is continuous.

T.H. Jordan: The SEM data presented
in Fig.
indicate
three
different
types
of morphology.
In reporting
the Raman Microprohe Analysis,
the
authors
refer
to measurements
made on several
arbitrary,
single
particles.
Oid
these
particles
include
samples of each of the three
different
types of morphology?
If so, is there
any relationship
between the carbonate
content
and the morphology?
Authors:
The Raman microprobe
spectra
of
single,
isolated
particles
were not correlated
with
the
different
morphological
types
of
calcified
deposits
recognized
by
scanning
e 1ectron microscopy
(cf. Fig 1).
Any presumed
relationship
between the microscopic
molecular
composition
(e.g.,
the carbonate
content)
of
these
deposits
and the observed
morphological
characteristics
need yet to be examined.

Reviewer II: (In reference
to Fig. 4)
What was
the
pH at
the
start
of the
equilibration
process?
Did the authors
vary the initial
pH
and, if so, did it have any effect
on the final
equi 1 i bra tion?
Authors: The deposits
were equilibrated
with 1
mM H3P04. The pH of the dissolving
medium was
not preadjusted.
Immediately
after
suspending
powdered deproteina ted deposit
10-Hy,
the pH
increased
sharply
due to dissolution
of the
so 1 id.

T.H. Jordan: If one converts
the data in Table
2 to 'J; by weight,
one discovers
that for (A)
only 86.7% of the weight
of the sample is
accounted for.
What is the rest of the sample?
The amount unaccounted
for is too great
to he
hydroxide or chloride
as the formula in Chemical
Composition section suggests.
Yet we are told in
the
Methods
section
that
a
quantitative
deproteination
technique was used.
What is the
other 13.3% of the sample?
Authors:
The deproteinated
calcified
deposits
are hydrated.
Our unpublished
TGA data show
average weight loss of 15% hy heating to 6oooc.

Reviewer 1I: If HAP is ruled
out as a major
equ1l1brat1ng
phase,
what replaces
it,
OCP or
the carbonate-containing
hydrolytic
products
of
OCP?
Authors:
The Ca/P
composition
of
deposits
var,es
from 1.6
1.8.
Present
solubility
information
rules
out
HAP as
a
major
equilibrating
phase.
We
suggest
that
cardiovascular
deposits
are best represented
as
a
series
of
carbonate-containing
OCP
hydrolyzates,
some OCP as documented by Hohling
et al. [23], and some material
that approaches
HAP in composition and structure.

Reviewer II: Don't the solubility
and dissolution
data presented
in this paper suggest that OCP is
more than just a transient
precursor
phase which
initiates
mineral
formation?
That is,
don't
these r!ata indicate
that f1CP was still
a sizable
mineral component in the deposits
examined?
nr
are the authors
suggesting
that the hydrolyzer!
carbonate-substituted
"defect
apatite"
products
have a solubility
product similar
to that of the
OCP precursor?
Authors: Our data indicate
that cardiovascular
deposit
is heterogeneous.
A fraction
of this
may be OCP, but at present,
we cannot suggest
the size of the OCP fraction.
As shown in Fig.
4,
the
solubility
range
of
cardiovascular
deposits
is unexr,ectedly
close to that of OCP.

Reviewer II: Please
explain
or
reference
how
values of n between 2 and 3 support a surface
control led rate process.
Authors:
The rate
of stirring
did not affect
the
rate
of
dissolution
of
cardiovascular
deposits
(present
work) or kidney stones
[35].
This
is
indicative
of
a
surface-diffusion
control led rate
process.
Such processes
are
characterized
by values of n = 2 or higher.
In
the opposite
case where volume diffusion
is the
rate
controlling
process,
dissolution
rate
is
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affecte<1
by the
stirring
characterized
by a reaction

rate
and can
order of n = 1.

of Cardiovascular
be

RevfewerII:Would it be too presumptuous to add a
statement
here that the "hydrolyzed,
carbonatesubstituted
products"
are
apatitic-like
in
lattice
structure
and composition hut more akin
to OCP in so far as solubility
behavior
is
concerned?
Couldn't
such
dichotomy
in
properties
suggest that the individual
particles
in the deposits
are comprised of an apatitic
core and an OCP-like surface coat?
Authors: The deprotei na ted deposits were groun<1
to very fine powder, which very likely
exposed
both "surface
coatings"
and "cores."
Contrary
to the suggestion,
just the opposite might he
the case---OCP cores trapped in coatings of OCPH
with
varying
<1egrees of
"maturation."
The
equilibrium
solubility
data
expressed
as
IAP(OCP) indicate
a gradual change in solubility
indicating
coexistence
of
a
series
of
OCP-hydrolyzates
of variable
solubilities.
This
approach
does not test
the hypothesis
that
apatitic
cores or coatings are present,
but this
possibility
cannot be rule<1 out.
The optical
microscopy
results
are not indicative
of the
presence of HAP.
A.C. Ne1son: The authors should be clear that
the mechanism of in vitro dissolution
of mineral
deposits
probably~
not characterize
the
mechanism of in vivo deposit
formation.
For
example, the eTTectol'
formation inhibitors
may
radically
alter the formation kinetics.
Authors:
Our solubility
data
anc1 optical
m1croscopi c
observations
provide
es se nti a 1
information
that cardiovascular
<1eposits arise
from OCP-like precursors,
forme<1 under in vivo
conditions.
The authors certainly
realize
that
fonnation
inhibitors
may
radically
alter
formation kinetics.
In addition,
inhibitors
may
control
the mechanism of pa thol ogi c deposition
by stabilizing
unstable
(i.e.,
more soluble)
precursors,
hence
preventing
formation
of
"mature" deposits.
A.C. Nelson:
More detail
on the preparation
of
samples for SEM EDX analysis
would be useful
especially
with
regard
to
minimization
of
mineral loss during preparation.
Authors:
The samples for SEM EDX analysis
were
prepared
by mechanically
crushing
hydrazine
deprotei na ted
deposits
as
outlined
in
the
Materials
and Methods section.
We do not
anti ci pate
significant
minera 1 1os ses during
sample preparation.
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